Advanced Or Metastatic Merkel Cell Carcinoma

3 clinical trials · Condition

Record	Firm	Date
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma (NCT06947928)	TuHURA Biosciences, Inc.	2025-12-11
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC) (NCT06940440)	TuHURA Biosciences, Inc.	2025-10-01
Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors (NCT03684785)	Exicure, Inc.	2018-12-13

Every clearance here is in the API, with alerts when new ones post.